USMCA Automotive Rules of Origin: Economic Impact and Operations, 2023 Report, 48495-48497 [2022-17064]
Download as PDF
<![CDATA[
jspears on DSK121TN23PROD with NOTICES
Federal Register / Vol. 87, No. 152 / Tuesday, August 9, 2022 / Notices
Netherlands; NXP USA, Inc. of Austin,
Texas; Avnet, Inc. of Phoenix, Arizona;
Arrow Electronics, Inc. of Centennial,
Colorado; Mouser Electronics, Inc. of
Mansfield, Texas; Continental AG and
Continental Automotive GmbH, both of
Hanover, Germany; Continental
Automotive Systems, Inc. of Auburn
Hills, Michigan; Robert Bosch GmbH of
Gerlingen-Schillerho¨he, Germany; and
Robert Bosch LLC of Farmington Hills,
Michigan (collectively, ‘‘Respondents’’).
The Office of Unfair Import
Investigations (‘‘OUII’’) is participating
in the investigation.
The Commission previously
terminated the investigation as to
certain claims of the ’928 patent, the
’474 patent, the ’017 patent, and the
’228 patent. See Order No. 16 (Feb. 9,
2022), unreviewed by Notice (Mar. 2,
2022); Order No. 21, unreviewed by
Notice (May 16, 2022).
On July 12, 2022, MediaTek and
Respondents filed a joint motion to
terminate the investigation in its
entirety based on a settlement
agreement (‘‘Agreement’’). On July 14,
2022, OUII filed a statement in support
of termination but expressed concerns
regarding the redactions to the public
version of the Agreement. On July 21,
2022, MediaTek and Respondents filed
a revised public version of the
Agreement.
On July 25, 2022, the presiding ALJ
issued the subject ID (Order No. 24),
granting the joint motion to terminate
the investigation based on settlement.
The ID finds that the motion for
termination satisfies Commission Rule
210.21(b) (19 CFR 210.21(b)) and that no
extraordinary circumstances exist that
would prevent the requested
termination. No petitions for review
were filed.
The Commission has determined not
to review the subject ID. The
investigation is terminated in its
entirety.
The Commission vote for this
determination took place on August 4,
2022.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended, 19 U.S.C. 1337, and in Part
210 of the Commission’s Rules of
Practice and Procedure, 19 CFR part
210.
By order of the Commission.
Issued: August 4, 2022.
Katherine M. Hiner,
Acting Secretary to the Commission.
[FR Doc. 2022–17068 Filed 8–8–22; 8:45 am]
BILLING CODE 7020–02–P
VerDate Sep<11>2014
18:04 Aug 08, 2022
Jkt 256001
48495
jennifer.andberg@usitc.gov). Hearingimpaired individuals may obtain
information on this matter by contacting
[Investigation No. 332–592]
the Commission’s TDD terminal at 202–
205–1810. General information
USMCA Automotive Rules of Origin:
concerning the Commission may also be
Economic Impact and Operations, 2023
obtained by accessing its website
Report
(https://www.usitc.gov). Persons with
mobility impairments who will need
ACTION: Notice of investigation and
special assistance in gaining access to
scheduling of a public hearing.
the Commission should contact the
SUMMARY: In accordance with the United Office of the Secretary at 202–205–2000.
States-Mexico-Canada Agreement
SUPPLEMENTARY INFORMATION:
Implementation Act (‘‘USMCA
Background: As required by the
Implementation Act’’) the U.S.
USMCA Implementation Act, the
International Trade Commission
Commission in its report will focus on
(Commission) instituted Investigation
USMCA automotive rules of origin
No. 332–592, USMCA Automotive Rules (ROO) and their effects on the U.S.
of Origin: Economic Impact and
economy, impacts to U.S.
Operations, 2023 Report.
competitiveness, and relevancy
considering recent technology changes.
DATES:
In particular, the USMCA
September 30, 2022: Deadline for
Implementation Act requires that the
filing requests to appear at the public
Commission report on:
hearing.
(1) the economic impact of USMCA
October 13, 2022: Deadline for filing
automotive ROO on U.S. gross domestic
prehearing briefs and statements.
product, trade, employment, and
October 27, 2022: Deadline for filing
consumers, as well as economic impact
electronic copies of oral hearing
on production, investment, capacity,
statements.
revenues, wages, and employment in
November 3, 2022: Public hearing.
U.S. automotive industries;
November 11, 2022: Deadline for
(2) the operation of USMCA
filing post-hearing briefs and
automotive ROO and their effects on the
statements.
competitiveness of U.S. automotive
November 24, 2022: Deadline for
production and trade;
filing all other written submissions.
(3) the relevancy of USMCA
June 30, 2023: Transmittal of
automotive ROO in light of recent
Commission report to Congress and
technology changes in the United States;
USTR.
and
ADDRESSES: All Commission offices are
(4) other matters the Commission
in the U.S. International Trade
considers
relevant to the economic
Commission Building, 500 E Street SW,
impact of the USMCA automotive ROO.
Washington, DC. Due to the COVID 19
The USMCA Implementation Act
pandemic, the Commission’s building is
currently closed to the public. Once the requires that the Commission transmit
building reopens, persons with mobility its report on July 1, 2023, one year
following submission of a USMCA
impairments who will need special
automotive ROO report by USTR, also
assistance in gaining access to the
required by the USMCA Implementation
Commission should contact the Office
Act. Because July 1, 2023, is a Saturday,
of the Secretary at 202–205–2000. The
the Commission expects to submit the
public record for this investigation may
report on Friday, June 30, 2023. The
be viewed on the Commission’s
Commission is directed to submit
electronic docket (EDIS) at https://
reports on USMCA automotive ROO
edis.usitc.gov.
every two years thereafter until 2031.
Public Hearing: A public hearing in
FOR FURTHER INFORMATION CONTACT:
connection with this investigation will
Project Leader Mitch Semanik
be held beginning at 9:30 a.m. on
(mitchell.semanik@usitc.gov or 202–
November 3, 2022. More detailed
205–2034), or Deputy Project Leader
information about the hearing,
Sharon Ford (202–204–3084 or
including how to participate, will be
sharon.ford@usitc.gov) for information
posted on the Commission’s website at
specific to these investigations. For
(https://usitc.gov/research_and_
information on the legal aspects of this
analysis/what_we_are_working_
investigation, contact William Gearhart
on.htm). Once on that web page, scroll
of the Commission’s Office of the
down to Investigation No. 332–592,
General Counsel (202–205–3091 or
USMCA Automotive Rules of Origin:
william.gearhart@usitc.gov). The media
should contact Jennifer Andberg, Office Economic Impact and Operations 2023
Report, and click on the link to
of External Relations (202–205–3404 or
INTERNATIONAL TRADE
COMMISSION
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
E:\FR\FM\09AUN1.SGM
09AUN1
jspears on DSK121TN23PROD with NOTICES
48496
Federal Register / Vol. 87, No. 152 / Tuesday, August 9, 2022 / Notices
‘‘Hearing Information.’’ Interested
parties should check the Commission’s
website periodically for updates.
Requests to appear at the public
hearing should be filed with the
Secretary no later than 5:15 p.m.,
September 30, 2022, in accordance with
the requirements in the ‘‘Written
Submissions’’ section below. All
prehearing briefs and statements should
be filed not later than 5:15 p.m., October
13, 2022. To facilitate the hearing,
including the preparation of an accurate
written transcript of the hearing, oral
testimony to be presented at the hearing
must be submitted to the Commission
electronically no later than noon,
October 27, 2022. All post-hearing briefs
and statements should be filed no later
than 5:15 p.m., November 11, 2022.
Post-hearing briefs and statements
should address matters raised at the
hearing. For a description of the
different types of written briefs and
statements, see the ‘‘Definitions’’ section
below.
In the event that, as of the close of
business on September 30, 2022, no
witnesses are scheduled to appear at the
hearing, the hearing will be canceled.
Any person interested in attending the
hearing as an observer or nonparticipant
should check the Commission website
in the preceding paragraph for
information concerning whether the
hearing will be held.
Written Submissions: In lieu of or in
addition to participating in the hearing,
interested parties are invited to file
written submissions concerning this
investigation. All written submissions
should be addressed to the Secretary
and should be received not later than
the dates provided for in this notice. All
written submissions must conform to
the provisions of section 201.8 of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.8), as
temporarily amended by 85 FR 15798
(March 19, 2020). Under that rule
waiver, the Office of the Secretary will
accept only electronic filings at this
time. Filings must be made through the
Commission’s Electronic Document
Information System (EDIS, https://
edis.usitc.gov). No in-person paperbased filings or paper copies of any
electronic filings will be accepted until
further notice. Persons with questions
regarding electronic filing should
contact the Office of the Secretary,
Docket Services Division (202–205–
1802), or consult the Commission’s
Handbook on Filing Procedures.
Definitions of Types of Documents
That May Be Filed; Requirements: In
addition to requests to appear at the
hearing, this notice provides for the
possible filing of four types of
VerDate Sep<11>2014
18:04 Aug 08, 2022
Jkt 256001
documents: prehearing briefs, oral
hearing statements, post-hearing briefs,
and other written submissions.
(1) Prehearing briefs refers to written
materials relevant to the investigation
and submitted in advance of the hearing
and includes written views on matters
that are the subject of the investigation,
supporting materials, and any other
written materials that you consider will
help the Commission in understanding
your views. You should file a
prehearing brief particularly if you plan
to testify at the hearing on behalf of an
industry group, company, or other
organization, and wish to provide
detailed views or information that will
support or supplement your testimony.
(2) Oral hearing statements
(testimony) refers to the actual oral
statement that you intend to present at
the public hearing. Do not include any
confidential business information in
that statement. If you plan to testify, you
must file a copy of your oral statement
by the date specified in this notice. This
statement will allow Commissioners to
understand your position in advance of
the hearing and will also assist the court
reporter in preparing an accurate
transcript of the hearing (e.g., names
spelled correctly).
(3) Post-hearing briefs refers to
submissions filed after the hearing by
persons who appeared at the hearing.
Such briefs: (a) should be limited to
matters that arose during the hearing, (b)
should respond to any Commissioner
and staff questions addressed to you at
the hearing, (c) should clarify, amplify,
or correct any statements you made at
the hearing, and (d) may, at your option,
address or rebut statements made by
other participants in the hearing.
(4) Other written submissions refer to
any other written submissions that
interested persons wish to make,
regardless of whether they appeared at
the hearing, and may include new
information or updates of information
previously provided.
There is no standard format that briefs
or other written submissions must
follow. However, each such document
must identify on its cover (1) the type
of document filed (i.e., prehearing brief,
oral statement of (name), post-hearing
brief, or written submission), (2) the
name of the person or organization
filing it, and (3) whether it contains
confidential business information (CBI).
If it contains CBI, it must comply with
the marking and other requirements set
out below in this notice relating to CBI.
Submitters of written documents (other
than oral hearing statements) are
encouraged to include a short summary
of their position or interest at the
beginning of the document, and a table
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
of contents when the document
addresses multiple issues.
Confidential Business Information:
Any submissions that contain
confidential business information must
also conform to the requirements of
section 201.6 of the Commission’s Rules
of Practice and Procedure (19 CFR
201.6). Section 201.6 of the rules
requires that the cover of the document
and the individual pages be clearly
marked as to whether they are the
‘‘confidential’’ or ‘‘non-confidential’’
version, and that the confidential
business information is clearly
identified by means of brackets. All
written submissions, except for
confidential business information, will
be made available for inspection by
interested parties.
As requested by the USTR, the
Commission will not include any
confidential business information in its
report. However, all information,
including confidential business
information, submitted in this
investigation may be disclosed to and
used: (i) by the Commission, its
employees and Offices, and contract
personnel (a) for developing or
maintaining the records of this or a
related proceeding, or (b) in internal
investigations, audits, reviews, and
evaluations relating to the programs,
personnel, and operations of the
Commission including under 5 U.S.C.
Appendix 3; or (ii) by U.S. government
employees and contract personnel for
cybersecurity purposes. The
Commission will not otherwise disclose
any confidential business information in
a way that would reveal the operations
of the firm supplying the information.
Summaries of Written Submissions:
Persons wishing to have a summary of
their position included in the report that
the Commission sends to the USTR
should include a summary with their
written submission and should mark the
summary as having been provided for
that purpose. The summary should be
clearly marked as ‘‘summary for
inclusion in the report’’ at the top of the
page. The summary may not exceed 500
words, should be in MS Word format or
a format that can be easily converted to
MS Word, and should not include any
confidential business information. The
summary will be published as provided
if it meets these requirements and is
germane to the subject matter of the
investigation. The Commission will list
the name of the organization furnishing
the summary and will include a link to
the Commission’s Electronic Document
Information System (EDIS) where the
full written submission can be found.
By order of the Commission.
E:\FR\FM\09AUN1.SGM
09AUN1
48497
Federal Register / Vol. 87, No. 152 / Tuesday, August 9, 2022 / Notices
Issued: August 4, 2022.
Katherine Hiner,
Acting Secretary to the Commission.
[FR Doc. 2022–17064 Filed 8–8–22; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1060]
Bulk Manufacturer of Controlled
Substances Application: Chemtos,
LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Chemtos, LLC has applied to
be registered as a bulk manufacturer of
SUMMARY:
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before October 11, 2022. Such
persons may also file a written request
for a hearing on the application on or
before October 11, 2022.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
In
accordance with 21 CFR 1301.33(a), this
is notice that on July 11, 2022, Chemtos,
LLC, 16713 Picadilly Court, Round
Rock, Texas 78664–8544, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
jspears on DSK121TN23PROD with NOTICES
Controlled substance
3-Fluoro-N-methylcathinone (3-FMC) .............................................................................................................................................
Cathinone .......................................................................................................................................................................................
Methcathinone ................................................................................................................................................................................
4-Fluoro-N-methylcathinone (4-FMC) .............................................................................................................................................
Para-Methoxymethamphetamine (PMMA), 1-(4-methoxyphenyl)-N-methylpropan-2-amine .........................................................
Pentedrone (a-methylaminovalerophenone) ..................................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ...................................................................................................................................
4-Methyl-N-ethylcathinone (4-MEC) ...............................................................................................................................................
Naphyrone ......................................................................................................................................................................................
N-Ethylamphetamine ......................................................................................................................................................................
N,N-Dimethylamphetamine ............................................................................................................................................................
Fenethylline ....................................................................................................................................................................................
Aminorex ........................................................................................................................................................................................
4-Methylaminorex (cis isomer) .......................................................................................................................................................
4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5dihydro-1,3-oxazol-2-amine).
Gamma Hydroxybutyric Acid ..........................................................................................................................................................
Methaqualone .................................................................................................................................................................................
Mecloqualone .................................................................................................................................................................................
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ..................................................................................................................
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ................................................................
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............................
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ................................
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .....................................
FUB-144 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) ..............................................................
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) ......................................................................................................................................
MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ......................................
FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate) ............
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .........................................................
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone ...................................................................................
5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) ........................................
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide ................................
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ........................
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ..............................................................
5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .......................
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .................................................
5F-EDMB-PINACA (ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ..........................................
5F-MDMB-PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ...............................................
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ..........
4F-MDMB-BINACA (4F-MDMB-BUTINACA or methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate)
MMB-CHMICA, AMB-CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) ........................
FUB-AKB48, FUB-APINACA, AKB48 N-(4-FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3carboximide).
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide .............................................................................
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ...................................................
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ..................................................................................................................
5F-CUMYL-PINACA, 5GT-25 (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) .....................................
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) ................................
VerDate Sep<11>2014
18:04 Aug 08, 2022
Jkt 256001
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
E:\FR\FM\09AUN1.SGM
09AUN1
Drug
code
Schedule
1233
1235
1237
1238
1245
1246
1248
1249
1258
1475
1480
1503
1585
1590
1595
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
2010
2565
2572
6250
7008
7010
7011
7012
7014
7019
7020
7021
7023
7024
7025
7031
7032
7033
7034
7035
7036
7041
7042
7043
7044
7047
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
7048
7049
7081
7083
7085
I
I
I
I
I
]]>Agencies
[Federal Register Volume 87, Number 152 (Tuesday, August 9, 2022)]
[Notices]
[Pages 48495-48497]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-17064]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 332-592]
USMCA Automotive Rules of Origin: Economic Impact and Operations,
2023 Report
ACTION: Notice of investigation and scheduling of a public hearing.
-----------------------------------------------------------------------
SUMMARY: In accordance with the United States-Mexico-Canada Agreement
Implementation Act (``USMCA Implementation Act'') the U.S.
International Trade Commission (Commission) instituted Investigation
No. 332-592, USMCA Automotive Rules of Origin: Economic Impact and
Operations, 2023 Report.
DATES:
September 30, 2022: Deadline for filing requests to appear at the
public hearing.
October 13, 2022: Deadline for filing prehearing briefs and
statements.
October 27, 2022: Deadline for filing electronic copies of oral
hearing statements.
November 3, 2022: Public hearing.
November 11, 2022: Deadline for filing post-hearing briefs and
statements.
November 24, 2022: Deadline for filing all other written
submissions.
June 30, 2023: Transmittal of Commission report to Congress and
USTR.
ADDRESSES: All Commission offices are in the U.S. International Trade
Commission Building, 500 E Street SW, Washington, DC. Due to the COVID
19 pandemic, the Commission's building is currently closed to the
public. Once the building reopens, persons with mobility impairments
who will need special assistance in gaining access to the Commission
should contact the Office of the Secretary at 202-205-2000. The public
record for this investigation may be viewed on the Commission's
electronic docket (EDIS) at https://edis.usitc.gov.
FOR FURTHER INFORMATION CONTACT: Project Leader Mitch Semanik
([email protected] or 202-205-2034), or Deputy Project Leader
Sharon Ford (202-204-3084 or [email protected]) for information
specific to these investigations. For information on the legal aspects
of this investigation, contact William Gearhart of the Commission's
Office of the General Counsel (202-205-3091 or
[email protected]). The media should contact Jennifer Andberg,
Office of External Relations (202-205-3404 or
[email protected]). Hearing-impaired individuals may obtain
information on this matter by contacting the Commission's TDD terminal
at 202-205-1810. General information concerning the Commission may also
be obtained by accessing its website (https://www.usitc.gov). Persons
with mobility impairments who will need special assistance in gaining
access to the Commission should contact the Office of the Secretary at
202-205-2000.
SUPPLEMENTARY INFORMATION:
Background: As required by the USMCA Implementation Act, the
Commission in its report will focus on USMCA automotive rules of origin
(ROO) and their effects on the U.S. economy, impacts to U.S.
competitiveness, and relevancy considering recent technology changes.
In particular, the USMCA Implementation Act requires that the
Commission report on:
(1) the economic impact of USMCA automotive ROO on U.S. gross
domestic product, trade, employment, and consumers, as well as economic
impact on production, investment, capacity, revenues, wages, and
employment in U.S. automotive industries;
(2) the operation of USMCA automotive ROO and their effects on the
competitiveness of U.S. automotive production and trade;
(3) the relevancy of USMCA automotive ROO in light of recent
technology changes in the United States; and
(4) other matters the Commission considers relevant to the economic
impact of the USMCA automotive ROO.
The USMCA Implementation Act requires that the Commission transmit
its report on July 1, 2023, one year following submission of a USMCA
automotive ROO report by USTR, also required by the USMCA
Implementation Act. Because July 1, 2023, is a Saturday, the Commission
expects to submit the report on Friday, June 30, 2023. The Commission
is directed to submit reports on USMCA automotive ROO every two years
thereafter until 2031.
Public Hearing: A public hearing in connection with this
investigation will be held beginning at 9:30 a.m. on November 3, 2022.
More detailed information about the hearing, including how to
participate, will be posted on the Commission's website at (https://usitc.gov/research_and_analysis/what_we_are_working_on.htm). Once on
that web page, scroll down to Investigation No. 332-592, USMCA
Automotive Rules of Origin: Economic Impact and Operations 2023 Report,
and click on the link to
[[Page 48496]]
``Hearing Information.'' Interested parties should check the
Commission's website periodically for updates.
Requests to appear at the public hearing should be filed with the
Secretary no later than 5:15 p.m., September 30, 2022, in accordance
with the requirements in the ``Written Submissions'' section below. All
prehearing briefs and statements should be filed not later than 5:15
p.m., October 13, 2022. To facilitate the hearing, including the
preparation of an accurate written transcript of the hearing, oral
testimony to be presented at the hearing must be submitted to the
Commission electronically no later than noon, October 27, 2022. All
post-hearing briefs and statements should be filed no later than 5:15
p.m., November 11, 2022. Post-hearing briefs and statements should
address matters raised at the hearing. For a description of the
different types of written briefs and statements, see the
``Definitions'' section below.
In the event that, as of the close of business on September 30,
2022, no witnesses are scheduled to appear at the hearing, the hearing
will be canceled. Any person interested in attending the hearing as an
observer or nonparticipant should check the Commission website in the
preceding paragraph for information concerning whether the hearing will
be held.
Written Submissions: In lieu of or in addition to participating in
the hearing, interested parties are invited to file written submissions
concerning this investigation. All written submissions should be
addressed to the Secretary and should be received not later than the
dates provided for in this notice. All written submissions must conform
to the provisions of section 201.8 of the Commission's Rules of
Practice and Procedure (19 CFR 201.8), as temporarily amended by 85 FR
15798 (March 19, 2020). Under that rule waiver, the Office of the
Secretary will accept only electronic filings at this time. Filings
must be made through the Commission's Electronic Document Information
System (EDIS, https://edis.usitc.gov). No in-person paper-based filings
or paper copies of any electronic filings will be accepted until
further notice. Persons with questions regarding electronic filing
should contact the Office of the Secretary, Docket Services Division
(202-205-1802), or consult the Commission's Handbook on Filing
Procedures.
Definitions of Types of Documents That May Be Filed; Requirements:
In addition to requests to appear at the hearing, this notice provides
for the possible filing of four types of documents: prehearing briefs,
oral hearing statements, post-hearing briefs, and other written
submissions.
(1) Prehearing briefs refers to written materials relevant to the
investigation and submitted in advance of the hearing and includes
written views on matters that are the subject of the investigation,
supporting materials, and any other written materials that you consider
will help the Commission in understanding your views. You should file a
prehearing brief particularly if you plan to testify at the hearing on
behalf of an industry group, company, or other organization, and wish
to provide detailed views or information that will support or
supplement your testimony.
(2) Oral hearing statements (testimony) refers to the actual oral
statement that you intend to present at the public hearing. Do not
include any confidential business information in that statement. If you
plan to testify, you must file a copy of your oral statement by the
date specified in this notice. This statement will allow Commissioners
to understand your position in advance of the hearing and will also
assist the court reporter in preparing an accurate transcript of the
hearing (e.g., names spelled correctly).
(3) Post-hearing briefs refers to submissions filed after the
hearing by persons who appeared at the hearing. Such briefs: (a) should
be limited to matters that arose during the hearing, (b) should respond
to any Commissioner and staff questions addressed to you at the
hearing, (c) should clarify, amplify, or correct any statements you
made at the hearing, and (d) may, at your option, address or rebut
statements made by other participants in the hearing.
(4) Other written submissions refer to any other written
submissions that interested persons wish to make, regardless of whether
they appeared at the hearing, and may include new information or
updates of information previously provided.
There is no standard format that briefs or other written
submissions must follow. However, each such document must identify on
its cover (1) the type of document filed (i.e., prehearing brief, oral
statement of (name), post-hearing brief, or written submission), (2)
the name of the person or organization filing it, and (3) whether it
contains confidential business information (CBI). If it contains CBI,
it must comply with the marking and other requirements set out below in
this notice relating to CBI. Submitters of written documents (other
than oral hearing statements) are encouraged to include a short summary
of their position or interest at the beginning of the document, and a
table of contents when the document addresses multiple issues.
Confidential Business Information: Any submissions that contain
confidential business information must also conform to the requirements
of section 201.6 of the Commission's Rules of Practice and Procedure
(19 CFR 201.6). Section 201.6 of the rules requires that the cover of
the document and the individual pages be clearly marked as to whether
they are the ``confidential'' or ``non-confidential'' version, and that
the confidential business information is clearly identified by means of
brackets. All written submissions, except for confidential business
information, will be made available for inspection by interested
parties.
As requested by the USTR, the Commission will not include any
confidential business information in its report. However, all
information, including confidential business information, submitted in
this investigation may be disclosed to and used: (i) by the Commission,
its employees and Offices, and contract personnel (a) for developing or
maintaining the records of this or a related proceeding, or (b) in
internal investigations, audits, reviews, and evaluations relating to
the programs, personnel, and operations of the Commission including
under 5 U.S.C. Appendix 3; or (ii) by U.S. government employees and
contract personnel for cybersecurity purposes. The Commission will not
otherwise disclose any confidential business information in a way that
would reveal the operations of the firm supplying the information.
Summaries of Written Submissions: Persons wishing to have a summary
of their position included in the report that the Commission sends to
the USTR should include a summary with their written submission and
should mark the summary as having been provided for that purpose. The
summary should be clearly marked as ``summary for inclusion in the
report'' at the top of the page. The summary may not exceed 500 words,
should be in MS Word format or a format that can be easily converted to
MS Word, and should not include any confidential business information.
The summary will be published as provided if it meets these
requirements and is germane to the subject matter of the investigation.
The Commission will list the name of the organization furnishing the
summary and will include a link to the Commission's Electronic Document
Information System (EDIS) where the full written submission can be
found.
By order of the Commission.
[[Page 48497]]
Issued: August 4, 2022.
Katherine Hiner,
Acting Secretary to the Commission.
[FR Doc. 2022-17064 Filed 8-8-22; 8:45 am]
BILLING CODE 7020-02-P
